Assignee
UNIV CHINA PHARMA
CN·31 granted patents·28 pending applications·32 citations·filing 1994–2025
Top patents by PatentIndex Score
59 records- 0195US12054478B2Compositions and methods for inhibiting phenyl triazole MLL1-WDR5 protein-protein interactionUNIV CHINA PHARMA·Filed 2022·Granted Aug 6, 2024·4 cites·3 claims
- 0294US11479545B2Compositions and methods for inhibiting phenyl triazole MLL1-WDR5 protein-protein interactionUNIV CHINA PHARMA·Filed 2020·Granted Oct 25, 2022·4 cites·10 claims
- 0379US11078250B2High-activity long-acting hypoglycemic fusion protein as well as preparation method and medical application thereofUNIV CHINA PHARMA·Filed 2019·Granted Aug 3, 2021·3 cites·7 claims
- 0475US9550792B2Polycyclic substituted pyrazole kinase activity inhibitors and use thereofUNIV CHINA PHARMA·Filed 2014·Granted Jan 24, 2017·6 cites·16 claims
- 0569US2025152626A1Construction and application of enhanced neutrophil drugUNIV CHINA PHARMA·Filed 2024·Application pending·0 cites
- 0667US11085022B2Inflammation-targeted neutrophil granulocyte drug delivery system and use thereofUNIV CHINA PHARMA·Filed 2014·Granted Aug 10, 2021·1 cites·17 claims
- 0767US6596321B1Pharmaceutical composition for treating angiocardiopathy and the method of producing thereofUNIV CHINA PHARMA·Filed 2000·Granted Jul 22, 2003·8 cites·9 claims
- 0865US2024376089A13-hydroxy-5-(isoxazol-5-yl) pyridine formylglycine compounds, preparation method, pharmaceutical composition and useUNIV CHINA PHARMA·Filed 2024·Application pending·0 cites
- 0964US12144881B2Cosmetic composition containing α-mangostin, method for preparation, and uses thereofUNIV CHINA PHARMA·Filed 2019·Granted Nov 19, 2024·0 cites·7 claims
- 1064US10875903B2Bifunctional fusion proteins to inhibit angiogenesis in tumor microenvironment and to activate adaptive immune responses and the genes and uses thereofUNIV CHINA PHARMA·Filed 2014·Granted Dec 29, 2020·1 cites·6 claims
- 1160US12383535B2Hydrogen peroxide-responsive KEAP1-NRF2 ppi inhibitor prodrug, and preparation method thereforUNIV CHINA PHARMA·Filed 2020·Granted Aug 12, 2025·0 cites·7 claims
- 1260US2024280493A1Cellular sensors based on surface-enhanced raman scattering and application thereofUNIV CHINA PHARMA·Filed 2023·Application pending·0 cites
- 1360US2024300893A1Small molecule compounds targeting srsf6 protein and their preparation methods and applicationsUNIV CHINA PHARMA·Filed 2024·Application pending·0 cites
- 1459US11504385B2Proteolysis targeting chimeric molecule, preparation method, and applicationUNIV CHINA PHARMA·Filed 2019·Granted Nov 22, 2022·0 cites·5 claims
- 1559US2023257355A1Hydroxamic acid-containing compound, and preparation method and use thereofUNIV CHINA PHARMA·Filed 2022·Application pending·0 cites
- 1659US2024342184A1Use of enhancer 3c1 in preparation of enhancer for interaction between fxr and caspase 8UNIV CHINA PHARMA·Filed 2024·Application pending·0 cites
- 1757US11541032B2Composition containing sumo inhibitor and applicationUNIV CHINA PHARMA·Filed 2019·Granted Jan 3, 2023·0 cites·8 claims
- 1857US2025129073A1Inhibitor of receptor-interacting protein kinase 1, and preparation method and use thereforUNIV CHINA PHARMA·Filed 2022·Application pending·0 cites
- 1956US2024391901A1Substituted heterocyclic compound containing alpha-ketone framework, and use thereofUNIV CHINA PHARMA·Filed 2022·Application pending·0 cites
- 2055US2024189429A1Method for anchoring and modifying nano-drug on surface of living cellUNIV CHINA PHARMA·Filed 2020·Application pending·0 cites
- 2154US12226476B2Helper epitope peptide and application thereofUNIV CHINA PHARMA·Filed 2019·Granted Feb 18, 2025·0 cites·12 claims
- 2254US2024148686A1Pharmaceutical composition of forskolin-isoforskolin and pentacyclic triterpenoid compound, and application thereofUNIV CHINA PHARMA·Filed 2021·Application pending·0 cites
- 2353US2025346579A1Pyridazinone compound and preparation method therefor, pharmaceutical composition thereof, and application thereofUNIV CHINA PHARMA·Filed 2022·Application pending·0 cites
- 2451US12453731B2Aniline-based WDR5 protein-protein interaction inhibitor, and preparation method and use thereofUNIV CHINA PHARMA·Filed 2019·Granted Oct 28, 2025·0 cites·18 claims
- 2551US2023416258A1Benzodiazepine compounds, and preparation method therefor and use thereofUNIV CHINA PHARMA·Filed 2021·Application pending·0 cites
- 2650US2022031612A1Uricase gel preparation for external use, preparation method therefor and use thereofUNIV CHINA PHARMA·Filed 2019·Application pending·0 cites
- 2750US2026070889A15-pyridine-1h-indazole compound, pharmaceutical composition, and useUNIV CHINA PHARMA·Filed 2022·Application pending·0 cites
- 2849US12331058B2SHP2 and CDK4/6 dual-target inhibitory compound and pharmaceutical composition containing the sameUNIV CHINA PHARMA·Filed 2022·Granted Jun 17, 2025·0 cites·6 claims
- 2949US7772230B2Chroman compound, processes for its preparation, and its pharmaceutical useUNIV CHINA PHARMA·Filed 2007·Granted Aug 10, 2010·0 cites·5 claims
- 3049US2024327408A1Compounds containing tetrahydronaphthyridinone or tetrahydropyridopyrimidinone skeleton, preparation method therefor and pharmaceutical use thereofUNIV CHINA PHARMA·Filed 2022·Application pending·0 cites
- 3149US2021220288A1Natural nanoparticle-medicine composition for treating alzheimer's disease, preparation method therefor and application thereofUNIV CHINA PHARMA·Filed 2018·Application pending·0 cites
- 3249US2024217921A1Cinnamoyl amino acid compound and use thereofUNIV CHINA PHARMA·Filed 2020·Application pending·0 cites
- 3348US12310944B2Selective butyrylcholinesterase inhibitor or pharmaceutically acceptable salt thereof, preparation method and use thereofUNIV CHINA PHARMA·Filed 2019·Granted May 27, 2025·0 cites·6 claims
- 3448US2021169779A1Ophthalmic drug preparation and uses thereofUNIV CHINA PHARMA·Filed 2018·Application pending·0 cites
- 3547US11773057B2Naphthalenesulfonamide compound, preparation method, and applicationUNIV CHINA PHARMA·Filed 2020·Granted Oct 3, 2023·0 cites·7 claims
- 3647US9822089B2R type of resveratrol dimer, preparation process therefor and purpose thereof in lowering blood sugar levelUNIV CHINA PHARMA·Filed 2014·Granted Nov 21, 2017·0 cites·2 claims
- 3747US2022331348A1Method of preparing pentacyclic triterpenoid saponins and drug compositionUNIV CHINA PHARMA·Filed 2020·Application pending·0 cites
- 3846US10639289B2Application of neuraminidase and inhibitors thereof in myocardial ischemia and myocardial infarctionUNIV CHINA PHARMA·Filed 2016·Granted May 5, 2020·0 cites·1 claims
- 3946US2021369756A1Use of cyclic adenosine monophosphate, derivative or prodrug thereof in preparation of drug for preventing and/or treating depressionUNIV CHINA PHARMA·Filed 2020·Application pending·0 cites
- 4044US2020222497A1Use of compositae-type cyclic peptide compound as cgas-sting signalling pathway inhibitorUNIV CHINA PHARMA·Filed 2018·Application pending·0 cites
- 4143US11021454B2Type of aryl benzofuran amidated derivative and medical use thereofUNIV CHINA PHARMA·Filed 2017·Granted Jun 1, 2021·0 cites·8 claims
- 4243US10442759B21-sulfonamido-4-aryloxy compounds, and preparation method and medicinal application thereofUNIV CHINA PHARMA·Filed 2016·Granted Oct 15, 2019·0 cites·11 claims
- 4342US11014895B2Heterocyclic urea compound, and drug composition and application thereofUNIV CHINA PHARMA·Filed 2018·Granted May 25, 2021·0 cites·5 claims
- 4442US2015065580A1Application of fluoxetine to treatment of depigmentation diseasesUNIV CHINA PHARMA·Filed 2012·Application pending·0 cites
- 4540US11304926B2Application of transient receptor potential cation channel TRPV3 in developing drug for preventing or treating psoriasisUNIV CHINA PHARMA·Filed 2020·Granted Apr 19, 2022·0 cites·2 claims
- 4640US2022387617A1Use of cd200 protein and cd200 fusion protein in preparing a drug for treating psoriasisUNIV CHINA PHARMA·Filed 2020·Application pending·0 cites
- 4739US11905230B2Phenoxyacetic acid derivatives, preparation method thereof and use thereof as medicamentUNIV CHINA PHARMA·Filed 2018·Granted Feb 20, 2024·0 cites·2 claims
- 4839US11572359B2PARP/PI3K double-target inhibit containing pyridopyrimidine structureUNIV CHINA PHARMA·Filed 2018·Granted Feb 7, 2023·0 cites·12 claims
- 4939US10526370B2Pentapeptide associated with integrin receptor alpha vbeta3UNIV CHINA PHARMA·Filed 2015·Granted Jan 7, 2020·0 cites·7 claims
- 5039US2021171579A1Inhibitor using plant cyclopeptide as effective component for lipid metabolic abnormalities in cancer cells and uses thereofUNIV CHINA PHARMA·Filed 2018·Application pending·0 cites
Showing the top 50 of 59 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when UNIV CHINA PHARMA files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →